2-chrysen-2-ylbenzo[h]quinoline;2-(6-chrysen-2-ylisoquinolin-8-yl)-1,10-phenanthroline;6-chrysen-2-yl-1-methylbenzimidazole;7-chrysen-2-yl-1-methylbenzimidazole;3-(4-chrysen-2-ylnaphthalen-1-yl)-1,10-phenanthroline;6-(3-chrysen-2-ylphenyl)isoquinoline;2-chrysen-2-ylpyridine;bis(7-(2-chrysen-2-yl-4-pyridinyl)quinoline);2-chrysen-2-ylpyrimidine;2-(2-chrysen-2-ylpyrimidin-4-yl)-1,10-phenanthroline;2-chrysen-2-yl-1,3,5-triazine;2-(4-chrysen-2-yl-1,3,5-triazin-2-yl)-1,10-phenanthroline

C392H244N30 — CID 158201598

IUPAC2-chrysen-2-ylbenzo[h]quinoline;2-(6-chrysen-2-ylisoquinolin-8-yl)-1,10-phenanthroline;6-chrysen-2-yl-1-methylbenzimidazole;7-chrysen-2-yl-1-methylbenzimidazole;3-(4-chrysen-2-ylnaphthalen-1-yl)-1,10-phenanthroline;6-(3-chrysen-2-ylphenyl)isoquinoline;2-chrysen-2-ylpyridine;bis(7-(2-chrysen-2-yl-4-pyridinyl)quinoline);2-chrysen-2-ylpyrimidine;2-(2-chrysen-2-ylpyrimidin-4-yl)-1,10-phenanthroline;2-chrysen-2-yl-1,3,5-triazine;2-(4-chrysen-2-yl-1,3,5-triazin-2-yl)-1,10-phenanthroline
SMILESCn1cnc2ccc(-c3ccc4c(ccc5c6ccccc6ccc45)c3)cc21.Cn1cnc2cccc(-c3ccc4c(ccc5c6ccccc6ccc45)c3)c21.c1cc(-c2ccc3cnccc3c2)cc(-c2ccc3c(ccc4c5ccccc5ccc34)c2)c1.c1ccc(-c2ccc3c(ccc4c5ccccc5ccc34)c2)nc1.c1ccc2c(c1)ccc1c3ccc(-c4cc(-c5ccc6ccc7cccnc7c6n5)c5cnccc5c4)cc3ccc21.c1ccc2c(c1)ccc1c3ccc(-c4ccc(-c5cnc6c(ccc7cccnc76)c5)c5ccccc45)cc3ccc21.c1ccc2c(c1)ccc1c3ccc(-c4ccc5ccc6ccccc6c5n4)cc3ccc21.c1ccc2c(c1)ccc1c3ccc(-c4nccc(-c5ccc6ccc7cccnc7c6n5)n4)cc3ccc21.c1ccc2c(c1)ccc1c3ccc(-c4ncnc(-c5ccc6ccc7cccnc7c6n5)n4)cc3ccc21.c1ccc2c(c1)ccc1c3ccc(-c4ncncn4)cc3ccc21.c1cnc(-c2ccc3c(ccc4c5ccccc5ccc34)c2)nc1.c1cnc2cc(-c3ccnc(-c4ccc5c(ccc6c7ccccc7ccc56)c4)c3)ccc2c1.c1cnc2cc(-c3ccnc(-c4ccc5c(ccc6c7ccccc7ccc56)c4)c3)ccc2c1
InChIInChI=1S/C40H24N2.C39H23N3.C34H20N4.C33H19N5.C33H21N.2C32H20N2.C31H19N.2C26H18N2.C23H15N.C22H14N2.C21H13N3/c1-2-8-31-25(6-1)13-17-38-32-16-14-27(22-28(32)15-18-37(31)38)33-19-20-34(36-10-4-3-9-35(33)36)30-23-29-12-11-26-7-5-21-41-39(26)40(29)42-24-30;1-2-6-31-24(4-1)9-14-34-32-13-10-27(20-28(32)11-15-33(31)34)30-21-29-17-19-40-23-36(29)35(22-30)37-16-12-26-8-7-25-5-3-18-41-38(25)39(26)42-37;1-2-6-26-21(4-1)9-14-29-27-13-11-25(20-24(27)10-15-28(26)29)34-36-19-17-31(38-34)30-16-12-23-8-7-22-5-3-18-35-32(22)33(23)37-30;1-2-6-25-20(4-1)9-14-28-26-13-11-24(18-23(26)10-15-27(25)28)32-35-19-36-33(38-32)29-16-12-22-8-7-21-5-3-17-34-30(21)31(22)37-29;1-2-7-30-22(4-1)10-14-33-31-13-11-26(20-28(31)12-15-32(30)33)24-6-3-5-23(18-24)25-8-9-29-21-34-17-16-27(29)19-25;2*1-2-6-27-21(4-1)9-13-30-28-12-11-26(18-25(28)10-14-29(27)30)32-20-24(15-17-34-32)23-8-7-22-5-3-16-33-31(22)19-23;1-3-7-25-20(5-1)11-16-29-26-15-13-24(19-23(26)12-17-28(25)29)30-18-14-22-10-9-21-6-2-4-8-27(21)31(22)32-30;1-28-16-27-25-8-4-7-22(26(25)28)19-10-12-21-18(15-19)11-14-23-20-6-3-2-5-17(20)9-13-24(21)23;1-28-16-27-25-13-9-19(15-26(25)28)18-7-10-22-20(14-18)8-12-23-21-5-3-2-4-17(21)6-11-24(22)23;1-2-6-19-16(5-1)8-12-22-20-11-10-18(23-7-3-4-14-24-23)15-17(20)9-13-21(19)22;1-2-5-18-15(4-1)6-10-21-19-9-8-17(22-23-12-3-13-24-22)14-16(19)7-11-20(18)21;1-2-4-17-14(3-1)5-9-20-18-8-7-16(21-23-12-22-13-24-21)11-15(18)6-10-19(17)20/h1-24H;1-23H;1-20H;1-19H;1-21H;2*1-20H;1-19H;2*2-16H,1H3;1-15H;1-14H;1-13H
InChIKeyGAZRBGFFOUYQCY-UHFFFAOYSA-N
MW5374.47 g/mol
LogP101.58
Rot. Bonds20

About 2-chrysen-2-ylbenzo[h]quinoline;2-(6-chrysen-2-ylisoquinolin-8-yl)-1,10-phenanthroline;6-chrysen-2-yl-1-methylbenzimidazole;7-chrysen-2-yl-1-methylbenzimidazole;3-(4-chrysen-2-ylnaphthalen-1-yl)-1,10-phenanthroline;6-(3-chrysen-2-ylphenyl)isoquinoline;2-chrysen-2-ylpyridine;bis(7-(2-chrysen-2-yl-4-pyridinyl)quinoline);2-chrysen-2-ylpyrimidine;2-(2-chrysen-2-ylpyrimidin-4-yl)-1,10-phenanthroline;2-chrysen-2-yl-1,3,5-triazine;2-(4-chrysen-2-yl-1,3,5-triazin-2-yl)-1,10-phenanthroline

2-chrysen-2-ylbenzo[h]quinoline;2-(6-chrysen-2-ylisoquinolin-8-yl)-1,10-phenanthroline;6-chrysen-2-yl-1-methylbenzimidazole;7-chrysen-2-yl-1-methylbenzimidazole;3-(4-chrysen-2-ylnaphthalen-1-yl)-1,10-phenanthroline;6-(3-chrysen-2-ylphenyl)isoquinoline;2-chrysen-2-ylpyridine;bis(7-(2-chrysen-2-yl-4-pyridinyl)quinoline);2-chrysen-2-ylpyrimidine;2-(2-chrysen-2-ylpyrimidin-4-yl)-1,10-phenanthroline;2-chrysen-2-yl-1,3,5-triazine;2-(4-chrysen-2-yl-1,3,5-triazin-2-yl)-1,10-phenanthroline (PubChem CID 158201598) has the molecular formula C392H244N30 and a molecular weight of 5374.47 g/mol. Its IUPAC name is 2-chrysen-2-ylbenzo[h]quinoline;2-(6-chrysen-2-ylisoquinolin-8-yl)-1,10-phenanthroline;6-chrysen-2-yl-1-methylbenzimidazole;7-chrysen-2-yl-1-methylbenzimidazole;3-(4-chrysen-2-ylnaphthalen-1-yl)-1,10-phenanthroline;6-(3-chrysen-2-ylphenyl)isoquinoline;2-chrysen-2-ylpyridine;bis(7-(2-chrysen-2-yl-4-pyridinyl)quinoline);2-chrysen-2-ylpyrimidine;2-(2-chrysen-2-ylpyrimidin-4-yl)-1,10-phenanthroline;2-chrysen-2-yl-1,3,5-triazine;2-(4-chrysen-2-yl-1,3,5-triazin-2-yl)-1,10-phenanthroline.

Molecular Properties

Compound Name2-chrysen-2-ylbenzo[h]quinoline;2-(6-chrysen-2-ylisoquinolin-8-yl)-1,10-phenanthroline;6-chrysen-2-yl-1-methylbenzimidazole;7-chrysen-2-yl-1-methylbenzimidazole;3-(4-chrysen-2-ylnaphthalen-1-yl)-1,10-phenanthroline;6-(3-chrysen-2-ylphenyl)isoquinoline;2-chrysen-2-ylpyridine;bis(7-(2-chrysen-2-yl-4-pyridinyl)quinoline);2-chrysen-2-ylpyrimidine;2-(2-chrysen-2-ylpyrimidin-4-yl)-1,10-phenanthroline;2-chrysen-2-yl-1,3,5-triazine;2-(4-chrysen-2-yl-1,3,5-triazin-2-yl)-1,10-phenanthroline
PubChem CID158201598
Molecular FormulaC392H244N30
Molecular Weight5374.47 g/mol
Exact Mass5370.00
IUPAC Name2-chrysen-2-ylbenzo[h]quinoline;2-(6-chrysen-2-ylisoquinolin-8-yl)-1,10-phenanthroline;6-chrysen-2-yl-1-methylbenzimidazole;7-chrysen-2-yl-1-methylbenzimidazole;3-(4-chrysen-2-ylnaphthalen-1-yl)-1,10-phenanthroline;6-(3-chrysen-2-ylphenyl)isoquinoline;2-chrysen-2-ylpyridine;bis(7-(2-chrysen-2-yl-4-pyridinyl)quinoline);2-chrysen-2-ylpyrimidine;2-(2-chrysen-2-ylpyrimidin-4-yl)-1,10-phenanthroline;2-chrysen-2-yl-1,3,5-triazine;2-(4-chrysen-2-yl-1,3,5-triazin-2-yl)-1,10-phenanthroline
SMILESCn1cnc2ccc(-c3ccc4c(ccc5c6ccccc6ccc45)c3)cc21.Cn1cnc2cccc(-c3ccc4c(ccc5c6ccccc6ccc45)c3)c21.c1cc(-c2ccc3cnccc3c2)cc(-c2ccc3c(ccc4c5ccccc5ccc34)c2)c1.c1ccc(-c2ccc3c(ccc4c5ccccc5ccc34)c2)nc1.c1ccc2c(c1)ccc1c3ccc(-c4cc(-c5ccc6ccc7cccnc7c6n5)c5cnccc5c4)cc3ccc21.c1ccc2c(c1)ccc1c3ccc(-c4ccc(-c5cnc6c(ccc7cccnc76)c5)c5ccccc45)cc3ccc21.c1ccc2c(c1)ccc1c3ccc(-c4ccc5ccc6ccccc6c5n4)cc3ccc21.c1ccc2c(c1)ccc1c3ccc(-c4nccc(-c5ccc6ccc7cccnc7c6n5)n4)cc3ccc21.c1ccc2c(c1)ccc1c3ccc(-c4ncnc(-c5ccc6ccc7cccnc7c6n5)n4)cc3ccc21.c1ccc2c(c1)ccc1c3ccc(-c4ncncn4)cc3ccc21.c1cnc(-c2ccc3c(ccc4c5ccccc5ccc34)c2)nc1.c1cnc2cc(-c3ccnc(-c4ccc5c(ccc6c7ccccc7ccc56)c4)c3)ccc2c1.c1cnc2cc(-c3ccnc(-c4ccc5c(ccc6c7ccccc7ccc56)c4)c3)ccc2c1
InChIInChI=1S/C40H24N2.C39H23N3.C34H20N4.C33H19N5.C33H21N.2C32H20N2.C31H19N.2C26H18N2.C23H15N.C22H14N2.C21H13N3/c1-2-8-31-25(6-1)13-17-38-32-16-14-27(22-28(32)15-18-37(31)38)33-19-20-34(36-10-4-3-9-35(33)36)30-23-29-12-11-26-7-5-21-41-39(26)40(29)42-24-30;1-2-6-31-24(4-1)9-14-34-32-13-10-27(20-28(32)11-15-33(31)34)30-21-29-17-19-40-23-36(29)35(22-30)37-16-12-26-8-7-25-5-3-18-41-38(25)39(26)42-37;1-2-6-26-21(4-1)9-14-29-27-13-11-25(20-24(27)10-15-28(26)29)34-36-19-17-31(38-34)30-16-12-23-8-7-22-5-3-18-35-32(22)33(23)37-30;1-2-6-25-20(4-1)9-14-28-26-13-11-24(18-23(26)10-15-27(25)28)32-35-19-36-33(38-32)29-16-12-22-8-7-21-5-3-17-34-30(21)31(22)37-29;1-2-7-30-22(4-1)10-14-33-31-13-11-26(20-28(31)12-15-32(30)33)24-6-3-5-23(18-24)25-8-9-29-21-34-17-16-27(29)19-25;2*1-2-6-27-21(4-1)9-13-30-28-12-11-26(18-25(28)10-14-29(27)30)32-20-24(15-17-34-32)23-8-7-22-5-3-16-33-31(22)19-23;1-3-7-25-20(5-1)11-16-29-26-15-13-24(19-23(26)12-17-28(25)29)30-18-14-22-10-9-21-6-2-4-8-27(21)31(22)32-30;1-28-16-27-25-8-4-7-22(26(25)28)19-10-12-21-18(15-19)11-14-23-20-6-3-2-5-17(20)9-13-24(21)23;1-28-16-27-25-13-9-19(15-26(25)28)18-7-10-22-20(14-18)8-12-23-21-5-3-2-4-17(21)6-11-24(22)23;1-2-6-19-16(5-1)8-12-22-20-11-10-18(23-7-3-4-14-24-23)15-17(20)9-13-21(19)22;1-2-5-18-15(4-1)6-10-21-19-9-8-17(22-23-12-3-13-24-22)14-16(19)7-11-20(18)21;1-2-4-17-14(3-1)5-9-20-18-8-7-16(21-23-12-22-13-24-21)11-15(18)6-10-19(17)20/h1-24H;1-23H;1-20H;1-19H;1-21H;2*1-20H;1-19H;2*2-16H,1H3;1-15H;1-14H;1-13H
InChIKeyGAZRBGFFOUYQCY-UHFFFAOYSA-N
XLogP101.58
TPSA370.78 Ų
H-Bond Donors
H-Bond Acceptors30
Rotatable Bonds20
Heavy Atoms422
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5005374.47
LogP ≤ 5101.58
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1030

Analyze 2-chrysen-2-ylbenzo[h]quinoline;2-(6-chrysen-2-ylisoquinolin-8-yl)-1,10-phenanthroline;6-chrysen-2-yl-1-methylbenzimidazole;7-chrysen-2-yl-1-methylbenzimidazole;3-(4-chrysen-2-ylnaphthalen-1-yl)-1,10-phenanthroline;6-(3-chrysen-2-ylphenyl)isoquinoline;2-chrysen-2-ylpyridine;bis(7-(2-chrysen-2-yl-4-pyridinyl)quinoline);2-chrysen-2-ylpyrimidine;2-(2-chrysen-2-ylpyrimidin-4-yl)-1,10-phenanthroline;2-chrysen-2-yl-1,3,5-triazine;2-(4-chrysen-2-yl-1,3,5-triazin-2-yl)-1,10-phenanthroline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-(6-chrysen-2-ylisoquinolin-8-yl)-1,10-phenanthroline;7-(7-chrysen-2-ylnaphthalen-2-yl)quinoline;6-(3-chrysen-2-ylphenyl)isoquinoline;7-(2-chrysen-2-yl-4-pyridinyl)quinoline;3-(8-chrysen-2-ylquinolin-5-yl)-1,10-phenanthroline;2-(4-chrysen-2-yl-1,3,5-triazin-2-yl)-1,10-phenanthroline
CID 159408634
2-[6-[6-(19-hexacyclo[14.7.1.02,15.03,8.09,14.020,24]tetracosa-1(23),2(15),3,5,7,9,11,13,16(24),17,19,21-dodecaenyl)naphthalen-2-yl]naphthalen-2-yl]-1,3,5-triazine;6-(19-hexacyclo[14.7.1.02,15.03,8.09,14.020,24]tetracosa-1(23),2(15),3,5,7,9,11,13,16(24),17,19,21-dodecaenyl)-8-phenylisoquinoline;2-(19-hexacyclo[14.7.1.02,15.03,8.09,14.020,24]tetracosa-1(23),2(15),3,5,7,9,11,13,16(24),17,19,21-dodecaenyl)-4-(6-phenylnaphthalen-1-yl)pyrimidine;7-[2-(19-hexacyclo[14.7.1.02,15.03,8.09,14.020,24]tetracosa-1(23),2(15),3,5,7,9,11,13,16(24),17,19,21-dodecaenyl)-4-pyridinyl]quinoline;2-[2-(19-hexacyclo[14.7.1.02,15.03,8.09,14.020,24]tetracosa-1(23),2(15),3,5,7,9,11,13,16(24),17,19,21-dodecaenyl)pyrimidin-4-yl]-1,10-phenanthroline;2-[4-(19-hexacyclo[14.7.1.02,15.03,8.09,14.020,24]tetracosa-1(23),2(15),3,5,7,9,11,13,16(24),17,19,21-dodecaenyl)-1,3,5-triazin-2-yl]-1,10-phenanthroline
CID 161176124
2-(6-benzo[c]phenanthren-5-ylisoquinolin-8-yl)-1,10-phenanthroline;3-(8-benzo[c]phenanthren-5-ylquinolin-5-yl)-1,10-phenanthroline;2-(4-benzo[c]phenanthren-5-yl-1,3,5-triazin-2-yl)-1,10-phenanthroline;5-[2-[8-(4-isoquinolin-6-ylpyrimidin-2-yl)benzo[c]phenanthren-3-yl]pyrimidin-4-yl]quinoline;5-[2-[3-(4-quinolin-5-yl-2-pyridinyl)benzo[c]phenanthren-8-yl]-4-pyridinyl]quinoline;3-[4-[3-(4-quinolin-3-yl-1,3,5-triazin-2-yl)benzo[c]phenanthren-8-yl]-1,3,5-triazin-2-yl]quinoline
CID 159352760
2-(6-chrysen-2-ylisoquinolin-8-yl)-8-[2-[6-(3-methylbenzimidazol-5-yl)-2-pyridinyl]benzo[c]phenanthren-7-yl]-1,10-phenanthroline
CID 137458955
9-benzo[c]phenanthren-2-ylbenzo[h]quinoline;6-benzo[c]phenanthren-2-yl-8-phenylisoquinoline;2-benzo[c]phenanthren-2-yl-4-phenyl-1,3,5-triazine;7-(2-benzo[c]phenanthren-2-yl-4-pyridinyl)quinoline;7-[2-(1,3-benzothiazol-7-yl)benzo[c]phenanthren-7-yl]-1,3-benzothiazole;methane;1-methyl-7-[1-(3-methylbenzimidazol-4-yl)benzo[c]phenanthren-7-yl]benzimidazole;2-pyridin-2-yl-4-[2-(4-pyridin-2-yl-1,3,5-triazin-2-yl)benzo[c]phenanthren-7-yl]-1,3,5-triazine
CID 159592553
2-benzo[c]phenanthren-2-ylbenzo[h]quinoline;9-benzo[c]phenanthren-2-ylbenzo[h]quinoline;9-(4-benzo[c]phenanthren-5-yl-6-carbazol-9-yl-1,3,5-triazin-2-yl)carbazole;6-benzo[c]phenanthren-2-yl-8-phenylisoquinoline;2-benzo[c]phenanthren-2-yl-4-phenyl-1,3,5-triazine;2-benzo[c]phenanthren-2-ylpyrimidine;9-(4-benzo[c]phenanthren-5-yl-6-triphenylen-2-yl-1,3,5-triazin-2-yl)carbazole;7-[2-(1,3-benzothiazol-7-yl)benzo[c]phenanthren-7-yl]-1,3-benzothiazole;6-(2-isoquinolin-6-ylbenzo[c]phenanthren-7-yl)isoquinoline;1-methyl-7-[1-(3-methylbenzimidazol-4-yl)benzo[c]phenanthren-7-yl]benzimidazole;2-[2-(1,3,5-triazin-2-yl)benzo[c]phenanthren-7-yl]-1,3,5-triazine
CID 159896596
2-[6,10-bis(1,3,5-triazin-2-yl)triphenylen-2-yl]-1,3,5-triazine;6-(7-isoquinolin-6-yltriphenylen-2-yl)isoquinoline;6-(6-naphthalen-2-yl-10-quinolin-6-yltriphenylen-2-yl)quinoline;6-(6-quinolin-6-yltriphenylen-2-yl)quinoline;8-(7-quinolin-8-yltriphenylen-2-yl)quinoline;2-[6-(1,3,5-triazin-2-yl)triphenylen-2-yl]-1,3,5-triazine;2-triphenylen-2-ylbenzo[h]quinoline;9-triphenylen-2-ylbenzo[h]quinoline
CID 158790436
2-[3,5-bis(6-phenyl-3-pyridinyl)phenyl]-4,6-dinaphthalen-1-yl-1,3,5-triazine;2-(3,5-diphenylphenyl)-4,6-bis(3-pyridin-2-ylphenyl)-1,3,5-triazine;2-(3,5-diphenylphenyl)-4,6-bis(3-pyrimidin-2-ylphenyl)pyrimidine;5-[3-(4,6-diphenylpyrimidin-2-yl)-5-phenanthren-9-ylphenyl]quinoline;2-(3,5-dipyridin-3-ylphenyl)-4,6-bis(3-phenylphenyl)-1,3,5-triazine;2-[3-phenanthren-9-yl-5-(3-pyridin-4-ylphenyl)phenyl]-4,6-diphenyl-1,3,5-triazine
CID 159224759
18-[3-(9,9-dimethylfluoren-2-yl)phenyl]pentacyclo[10.7.1.02,7.08,20.013,18]icosa-1(19),2(7),3,5,8(20),9,11,13,15,17-decaene;2-(9-hexacyclo[16.8.0.02,11.03,8.012,17.020,25]hexacosa-1(26),2(11),3,5,7,9,12,14,16,18,20,22,24-tridecaenyl)benzo[h]quinoline;2-(9-hexacyclo[16.8.0.02,11.03,8.012,17.021,26]hexacosa-1(18),2(11),3,5,7,9,12,14,16,19,21,23,25-tridecaenyl)benzo[h]quinoline;6-(9-hexacyclo[16.8.0.02,11.03,8.012,17.021,26]hexacosa-1(18),2(11),3,5,7,9,12,14,16,19,21,23,25-tridecaenyl)isoquinoline;2-(9-hexacyclo[16.8.0.02,11.03,8.012,17.021,26]hexacosa-1(18),2(11),3,5,7,9,12,14,16,19,21,23,25-tridecaenyl)pyrimidine;6-(9-hexacyclo[16.8.0.02,11.03,8.012,17.021,26]hexacosa-1(18),2(11),3,5,7,9,12,14,16,19,21,23,25-tridecaenyl)quinoxaline;2-(9-hexacyclo[16.8.0.02,11.03,8.012,17.021,26]hexacosa-1(18),2(11),3,5,7,9,12,14,16,19,21,23,25-tridecaenyl)-1,3,5-triazine;3-(3-pentacyclo[10.7.1.02,7.08,20.013,18]icosa-1(19),2(7),3,5,8(20),9,11,13,15,17-decaen-18-ylphenyl)-9-phenylcarbazole;18-phenylpentacyclo[10.7.1.02,7.08,20.013,18]icosa-1(19),2(7),3,5,8(20),9,11,13,15,17-decaene;18-(4-phenylphenyl)pentacyclo[10.7.1.02,7.08,20.013,18]icosa-1(19),2(7),3,5,8(20),9,11,13,15,17-decaene
CID 157230673
3-[3,8-bis(3-quinolin-6-ylphenyl)phenanthren-1-yl]-8-[3-[1-(3-quinolin-8-ylphenyl)phenanthren-3-yl]phenyl]quinoline
CID 137458731
2-[4-[6-[2-(1,3,5-triazin-2-yl)quinolin-6-yl]quinolin-2-yl]naphthalen-1-yl]-1,10-phenanthroline;2-[6-[6-[2-(1,3,5-triazin-2-yl)quinolin-6-yl]quinolin-2-yl]naphthalen-2-yl]-1,10-phenanthroline
CID 157057825
2-[3,5-di(quinolin-3-yl)phenyl]-7-(2-pyridin-2-ylquinolin-7-yl)quinoline;2-pyridin-2-yl-7-[2-(3-quinolin-3-ylphenyl)quinolin-7-yl]quinoline;2-[7-(2-pyridin-2-ylquinolin-7-yl)quinolin-2-yl]-1,10-phenanthroline
CID 165071745

Frequently Asked Questions

What is the IUPAC name of 2-chrysen-2-ylbenzo[h]quinoline;2-(6-chrysen-2-ylisoquinolin-8-yl)-1,10-phenanthroline;6-chrysen-2-yl-1-methylbenzimidazole;7-chrysen-2-yl-1-methylbenzimidazole;3-(4-chrysen-2-ylnaphthalen-1-yl)-1,10-phenanthroline;6-(3-chrysen-2-ylphenyl)isoquinoline;2-chrysen-2-ylpyridine;bis(7-(2-chrysen-2-yl-4-pyridinyl)quinoline);2-chrysen-2-ylpyrimidine;2-(2-chrysen-2-ylpyrimidin-4-yl)-1,10-phenanthroline;2-chrysen-2-yl-1,3,5-triazine;2-(4-chrysen-2-yl-1,3,5-triazin-2-yl)-1,10-phenanthroline?
The IUPAC name of 2-chrysen-2-ylbenzo[h]quinoline;2-(6-chrysen-2-ylisoquinolin-8-yl)-1,10-phenanthroline;6-chrysen-2-yl-1-methylbenzimidazole;7-chrysen-2-yl-1-methylbenzimidazole;3-(4-chrysen-2-ylnaphthalen-1-yl)-1,10-phenanthroline;6-(3-chrysen-2-ylphenyl)isoquinoline;2-chrysen-2-ylpyridine;bis(7-(2-chrysen-2-yl-4-pyridinyl)quinoline);2-chrysen-2-ylpyrimidine;2-(2-chrysen-2-ylpyrimidin-4-yl)-1,10-phenanthroline;2-chrysen-2-yl-1,3,5-triazine;2-(4-chrysen-2-yl-1,3,5-triazin-2-yl)-1,10-phenanthroline (CID 158201598) is 2-chrysen-2-ylbenzo[h]quinoline;2-(6-chrysen-2-ylisoquinolin-8-yl)-1,10-phenanthroline;6-chrysen-2-yl-1-methylbenzimidazole;7-chrysen-2-yl-1-methylbenzimidazole;3-(4-chrysen-2-ylnaphthalen-1-yl)-1,10-phenanthroline;6-(3-chrysen-2-ylphenyl)isoquinoline;2-chrysen-2-ylpyridine;bis(7-(2-chrysen-2-yl-4-pyridinyl)quinoline);2-chrysen-2-ylpyrimidine;2-(2-chrysen-2-ylpyrimidin-4-yl)-1,10-phenanthroline;2-chrysen-2-yl-1,3,5-triazine;2-(4-chrysen-2-yl-1,3,5-triazin-2-yl)-1,10-phenanthroline.
What is the SMILES notation for 2-chrysen-2-ylbenzo[h]quinoline;2-(6-chrysen-2-ylisoquinolin-8-yl)-1,10-phenanthroline;6-chrysen-2-yl-1-methylbenzimidazole;7-chrysen-2-yl-1-methylbenzimidazole;3-(4-chrysen-2-ylnaphthalen-1-yl)-1,10-phenanthroline;6-(3-chrysen-2-ylphenyl)isoquinoline;2-chrysen-2-ylpyridine;bis(7-(2-chrysen-2-yl-4-pyridinyl)quinoline);2-chrysen-2-ylpyrimidine;2-(2-chrysen-2-ylpyrimidin-4-yl)-1,10-phenanthroline;2-chrysen-2-yl-1,3,5-triazine;2-(4-chrysen-2-yl-1,3,5-triazin-2-yl)-1,10-phenanthroline?
The canonical SMILES for 2-chrysen-2-ylbenzo[h]quinoline;2-(6-chrysen-2-ylisoquinolin-8-yl)-1,10-phenanthroline;6-chrysen-2-yl-1-methylbenzimidazole;7-chrysen-2-yl-1-methylbenzimidazole;3-(4-chrysen-2-ylnaphthalen-1-yl)-1,10-phenanthroline;6-(3-chrysen-2-ylphenyl)isoquinoline;2-chrysen-2-ylpyridine;bis(7-(2-chrysen-2-yl-4-pyridinyl)quinoline);2-chrysen-2-ylpyrimidine;2-(2-chrysen-2-ylpyrimidin-4-yl)-1,10-phenanthroline;2-chrysen-2-yl-1,3,5-triazine;2-(4-chrysen-2-yl-1,3,5-triazin-2-yl)-1,10-phenanthroline is Cn1cnc2ccc(-c3ccc4c(ccc5c6ccccc6ccc45)c3)cc21.Cn1cnc2cccc(-c3ccc4c(ccc5c6ccccc6ccc45)c3)c21.c1cc(-c2ccc3cnccc3c2)cc(-c2ccc3c(ccc4c5ccccc5ccc34)c2)c1.c1ccc(-c2ccc3c(ccc4c5ccccc5ccc34)c2)nc1.c1ccc2c(c1)ccc1c3ccc(-c4cc(-c5ccc6ccc7cccnc7c6n5)c5cnccc5c4)cc3ccc21.c1ccc2c(c1)ccc1c3ccc(-c4ccc(-c5cnc6c(ccc7cccnc76)c5)c5ccccc45)cc3ccc21.c1ccc2c(c1)ccc1c3ccc(-c4ccc5ccc6ccccc6c5n4)cc3ccc21.c1ccc2c(c1)ccc1c3ccc(-c4nccc(-c5ccc6ccc7cccnc7c6n5)n4)cc3ccc21.c1ccc2c(c1)ccc1c3ccc(-c4ncnc(-c5ccc6ccc7cccnc7c6n5)n4)cc3ccc21.c1ccc2c(c1)ccc1c3ccc(-c4ncncn4)cc3ccc21.c1cnc(-c2ccc3c(ccc4c5ccccc5ccc34)c2)nc1.c1cnc2cc(-c3ccnc(-c4ccc5c(ccc6c7ccccc7ccc56)c4)c3)ccc2c1.c1cnc2cc(-c3ccnc(-c4ccc5c(ccc6c7ccccc7ccc56)c4)c3)ccc2c1.
What is the InChIKey of 2-chrysen-2-ylbenzo[h]quinoline;2-(6-chrysen-2-ylisoquinolin-8-yl)-1,10-phenanthroline;6-chrysen-2-yl-1-methylbenzimidazole;7-chrysen-2-yl-1-methylbenzimidazole;3-(4-chrysen-2-ylnaphthalen-1-yl)-1,10-phenanthroline;6-(3-chrysen-2-ylphenyl)isoquinoline;2-chrysen-2-ylpyridine;bis(7-(2-chrysen-2-yl-4-pyridinyl)quinoline);2-chrysen-2-ylpyrimidine;2-(2-chrysen-2-ylpyrimidin-4-yl)-1,10-phenanthroline;2-chrysen-2-yl-1,3,5-triazine;2-(4-chrysen-2-yl-1,3,5-triazin-2-yl)-1,10-phenanthroline?
The InChIKey is GAZRBGFFOUYQCY-UHFFFAOYSA-N. The full InChI is InChI=1S/C40H24N2.C39H23N3.C34H20N4.C33H19N5.C33H21N.2C32H20N2.C31H19N.2C26H18N2.C23H15N.C22H14N2.C21H13N3/c1-2-8-31-25(6-1)13-17-38-32-16-14-27(22-28(32)15-18-37(31)38)33-19-20-34(36-10-4-3-9-35(33)36)30-23-29-12-11-26-7-5-21-41-39(26)40(29)42-24-30;1-2-6-31-24(4-1)9-14-34-32-13-10-27(20-28(32)11-15-33(31)34)30-21-29-17-19-40-23-36(29)35(22-30)37-16-12-26-8-7-25-5-3-18-41-38(25)39(26)42-37;1-2-6-26-21(4-1)9-14-29-27-13-11-25(20-24(27)10-15-28(26)29)34-36-19-17-31(38-34)30-16-12-23-8-7-22-5-3-18-35-32(22)33(23)37-30;1-2-6-25-20(4-1)9-14-28-26-13-11-24(18-23(26)10-15-27(25)28)32-35-19-36-33(38-32)29-16-12-22-8-7-21-5-3-17-34-30(21)31(22)37-29;1-2-7-30-22(4-1)10-14-33-31-13-11-26(20-28(31)12-15-32(30)33)24-6-3-5-23(18-24)25-8-9-29-21-34-17-16-27(29)19-25;2*1-2-6-27-21(4-1)9-13-30-28-12-11-26(18-25(28)10-14-29(27)30)32-20-24(15-17-34-32)23-8-7-22-5-3-16-33-31(22)19-23;1-3-7-25-20(5-1)11-16-29-26-15-13-24(19-23(26)12-17-28(25)29)30-18-14-22-10-9-21-6-2-4-8-27(21)31(22)32-30;1-28-16-27-25-8-4-7-22(26(25)28)19-10-12-21-18(15-19)11-14-23-20-6-3-2-5-17(20)9-13-24(21)23;1-28-16-27-25-13-9-19(15-26(25)28)18-7-10-22-20(14-18)8-12-23-21-5-3-2-4-17(21)6-11-24(22)23;1-2-6-19-16(5-1)8-12-22-20-11-10-18(23-7-3-4-14-24-23)15-17(20)9-13-21(19)22;1-2-5-18-15(4-1)6-10-21-19-9-8-17(22-23-12-3-13-24-22)14-16(19)7-11-20(18)21;1-2-4-17-14(3-1)5-9-20-18-8-7-16(21-23-12-22-13-24-21)11-15(18)6-10-19(17)20/h1-24H;1-23H;1-20H;1-19H;1-21H;2*1-20H;1-19H;2*2-16H,1H3;1-15H;1-14H;1-13H.
What are the key properties of 2-chrysen-2-ylbenzo[h]quinoline;2-(6-chrysen-2-ylisoquinolin-8-yl)-1,10-phenanthroline;6-chrysen-2-yl-1-methylbenzimidazole;7-chrysen-2-yl-1-methylbenzimidazole;3-(4-chrysen-2-ylnaphthalen-1-yl)-1,10-phenanthroline;6-(3-chrysen-2-ylphenyl)isoquinoline;2-chrysen-2-ylpyridine;bis(7-(2-chrysen-2-yl-4-pyridinyl)quinoline);2-chrysen-2-ylpyrimidine;2-(2-chrysen-2-ylpyrimidin-4-yl)-1,10-phenanthroline;2-chrysen-2-yl-1,3,5-triazine;2-(4-chrysen-2-yl-1,3,5-triazin-2-yl)-1,10-phenanthroline?
2-chrysen-2-ylbenzo[h]quinoline;2-(6-chrysen-2-ylisoquinolin-8-yl)-1,10-phenanthroline;6-chrysen-2-yl-1-methylbenzimidazole;7-chrysen-2-yl-1-methylbenzimidazole;3-(4-chrysen-2-ylnaphthalen-1-yl)-1,10-phenanthroline;6-(3-chrysen-2-ylphenyl)isoquinoline;2-chrysen-2-ylpyridine;bis(7-(2-chrysen-2-yl-4-pyridinyl)quinoline);2-chrysen-2-ylpyrimidine;2-(2-chrysen-2-ylpyrimidin-4-yl)-1,10-phenanthroline;2-chrysen-2-yl-1,3,5-triazine;2-(4-chrysen-2-yl-1,3,5-triazin-2-yl)-1,10-phenanthroline has a molecular weight of 5374.47 g/mol, XLogP of 101.58, 20 rotatable bonds, 0 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for 2-chrysen-2-ylbenzo[h]quinoline;2-(6-chrysen-2-ylisoquinolin-8-yl)-1,10-phenanthroline;6-chrysen-2-yl-1-methylbenzimidazole;7-chrysen-2-yl-1-methylbenzimidazole;3-(4-chrysen-2-ylnaphthalen-1-yl)-1,10-phenanthroline;6-(3-chrysen-2-ylphenyl)isoquinoline;2-chrysen-2-ylpyridine;bis(7-(2-chrysen-2-yl-4-pyridinyl)quinoline);2-chrysen-2-ylpyrimidine;2-(2-chrysen-2-ylpyrimidin-4-yl)-1,10-phenanthroline;2-chrysen-2-yl-1,3,5-triazine;2-(4-chrysen-2-yl-1,3,5-triazin-2-yl)-1,10-phenanthroline is sourced from PubChem (CID 158201598), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).